Ventria Bioscience Products

Ventria has commercialized nine products through 2011. Ventria’s products target three business segments:

Human Health

• Recombinant lactoferrin
• Recombinant lysozyme
• Recombinant albumin
• Recombinant transferrin

Zoonotic Disease

• Reservoir targeted oral lyme disease vaccine
• Reservoir targeted oral rabies vaccine

Cell Culture & Biomanufacturing

• Multiple recombinant proteins and peptides that are used in the following applications:
  • Optimize performance and eliminate animal components and blood products in biomanufacturing, cell-based vaccines, cellular therapy, and regenerative medicine,
  • Biopharmaceutical formulation,
  • Diagnostics, and
  • Medical devices.